Cuba's Abdala coronavirus candidate vaccine showed "efficacy" of more than 92 percent after three doses, its maker said Monday, though it did not specify whether this was measured against infection, disease, or death.
AFP
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business